Affinity Asset Advisors, LLC
Top Portfolio Positions
97 positions ·
$1,934,339,612 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
200,000 | $130,068,000 | 6.72% | |
| APGE |
Apogee Therapeutics, Inc.
Healthcare
|
1,284,926 | $108,152,221 | 5.59% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
1,675,000 | $97,401,250 | 5.04% | |
| ERAS |
Erasca, Inc.
Healthcare
|
5,350,000 | $86,563,000 | 4.48% | |
| INSM |
INSMED Inc
Healthcare
|
480,000 | $78,489,600 | 4.06% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
2,800,000 | $77,560,000 | 4.01% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
1,279,134 | $64,519,518 | 3.34% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
26,271,802 | $58,323,399 | 3.02% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
1,400,000 | $55,608,000 | 2.87% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
170,000 | $54,772,300 | 2.83% |
Portfolio Trend
22 quarters · across all stocks
Holdings in OVID
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,710,774 | 15,635,484 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $23,612,625 | 10,636,318 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $11,654,500 | 7,150,000 | Shares | Sole | 2026-02-13 | |
| 2025-12-11 | $20,046,123 | 12,149,166 | Shares | Sole | 2025-12-18 | |
| 2025-09-30 | $3,445,000 | 2,650,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $220,280 | 667,516 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $208,264 | 667,516 | Shares | Sole | 2025-05-14 | |
| No 13F history on record for this holder in this stock. | ||||||